High urine osmolality and elevated urine sodium predict early nonresponse to fluid restriction in patients with the syndrome of inappropriate antidiuresis
In brief
In SIAD, two urine measures identify patients with 94% fluid-restriction nonresponse
Among 229 patients with SIAD treated with fluid restriction, 62% failed to raise blood sodium by more than 3 mmol/L in 24 hours. Urine osmolality above 500 mOsm/kg plus urine sodium above 130 mmol/L identified a group with a 94% nonresponse rate, supporting consideration of early second-line treatment; the findings come from a secondary analysis and need clinical context.
- Journal
- Journal of internal medicine (Q1)
- Published
- 7 October 2026
- Study design
- Prospective / inception cohort
- Evidence level
- Level 2, Moderate (CEBM 2b)
- Authors
- Michelle Patricia Müller, Laura Potasso, Ewout J Hoorn, Julie Refardt, Mirjam Christ-Crain
- PMID
- 42841275
- DOI
- 10.1111/joim.70167
Why clinicians should know about it
- Picked for Internal Medicine (paper of the day, 9 October 2026): Urine osmolality >500 mOsm/kg predicts SIAD fluid‑restriction failure
Abstract
INTRODUCTION: Fluid restriction is the current first-line therapy for hyponatremia induced by the syndrome of inappropriate antidiuresis (SIAD), yet up to 50% of patients do not achieve an adequate plasma sodium correction. Reported predictors of nonresponse include urine osmolality >500 mOsm/kg, the Furst ratio >1 [(UNa + UK)/(PNa)], urine sodium >130 mmol/L, and plasma urea >5 mmol/L. This study aimed to validate these cutoffs in an independent cohort. METHODS: This is a predefined secondary analysis of a randomized, controlled, prospective, and multicenter hyponatremia trial (plasma sodium <130 mmol/L). Response to fluid restriction was defined as an increase in plasma sodium of >3 mmol/L within the first 24 h. RESULTS: Of 839 patients with SIAD, 229 were treated with fluid restriction within the first 24 h and had complete laboratory data. Among these patients, 86 (38%) were classified as responders and 143 (62%) as nonresponders. Higher urine osmolality (p = 0.015) and higher plasma sodium levels (p < 0.001) were independently associated with nonresponse in multivariable logistic regression analysis. Urine osmolality >500 mOsm/kg had a specificity of 78% (positive likelihood ratio (LR+) 1.68), whereas urine sodium >130 mmol/L had a specificity of 97% (LR+ 3.81). The combination of both cutoffs markedly improved discriminatory performance (LR+ 9.62, positive predictive value 0.94). CONCLUSION: The present study validated urine osmolality >500 mOsm/kg and urine sodium >130 mmol/L as cutoffs for predicting nonresponse to fluid restriction in patients with SIAD. Combining both cutoffs identifies patients at high risk of nonresponse, in whom early initiation of second-line therapy should be strongly considered.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.